Head of the Centre for Psychedelic Research, Imperial College
Robin is pushing the boundaries with hallucinogenic drugs.
Robin’s rigorous research into psychedelics has gained attention largely because of the therapeutic potential these drugs may have for a variety of emotional and mental disturbances. He is the first scientist to test LSD on humans in more than 40 years. At Imperial, he has designed and carried out brain imaging studies using psychedelic compounds including LSD, DMT (from the ayahuasca vine), and psilocybin (from mushrooms).
The research Robin has undertaken is helping uncover and understand the psychology and biology of death and dying through stimulating NDEs (near-death experiences); has been shown to alleviate the major symptoms of depression; and raises the possibility that the use of psilocybin can create lasting changes in people’s mental outlooks and even political perspectives.
Robin obtained a Ph.D in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University. In 2019, he set up the Centre for Psychedelic Research at Imperial College London with the generous support of its founders.